Oura Ring Stock: Is an IPO the Right Fit?
This page contains links to our partners. We may be compensated when a link is clicked. Read the disclosures to learn more.
Explore potential ways to buy Oura Ring stock before the IPO. Get access to select pre-IPO startups like OpenAI, Databricks, Canva, and Anduril via the Fundrise Innovation Fund.
Table of Contents
Notable Oura Ring News
02/12/2025: How Oura Bridged the Tech Bro Gap
12/20/2024: Oura closes $200M round; CEO says it is profitable
12/19/2024: ŌURA Secures $200 Million in Series D Funding
11/19/2024: Dexcom and ŌURA Announce Strategic Partnership
Older news…
About Oura Ring
ŌURA Health was founded in 2013 by Petteri Lahtela, Kari Kivelä, and Markku Koskela, who envisioned a wearable technology that measures sleep and other metrics to improve overall health.
The company’s primary product, the Oura Ring, launched in 2015. It’s a “smart ring” that monitors sleep, activity, and readiness through advanced sensors and algorithms.
By combining biometric data with an integrated smartphone app, Oura empowers users to make healthier lifestyle choices. The company’s headquarters are in Oulu, Finland, with offices in San Francisco and Helsinki.
Oura competes in the highly competitive wearable technology market alongside brands like Apple, Fitbit, and WHOOP, differentiating itself with its sleek design and sleep-focused capabilities.
As consumer interest in personalized health tracking continues to grow and wearable technologies pursue broader functionality like blood sugar monitoring, mental health, fertility, and hydration, the appetite for these products will likely increase.
Partnership potential may also increase as fitness brands and medical researchers look for innovative ways to expand what is possible.
Here’s a brief video introducing the Oura Ring 4:
Ownership
Oura Ring is a venture-backed startup. Equity ownership includes the founders, employees, and venture capital firms.
The company has raised about $550 million in venture capital funding. The latest funding round was a Series D, which raised $200 million and was completed in December 2024.
Notable venture capital investors include Fidelity, Dexcom (DXCM), Forerunner Ventures, Gradient Ventures (Google), Temasek Holdings, The Chernin Group, DFO Management (Michael Dell), Block (SQ), Metaplanet Holdings, Bedford Ridge Capital, Eisai, Elysian Park Ventures, JAZZ Venture Partners, Lifeline Ventures, Next Ventures, One Capital, Jaan Tallinn, Joichi Ito, The Dreamers Fund (Will Smith), Time Ventures (Marc Benioff), Next Ventures (Lance Armstrong), and Shaquille O’Neil.
Funding Rounds
Round | Date | Est. Valuation | Raise Amount | Price |
---|---|---|---|---|
Series D | 12/19/24 | $5.20B | $200.00M | NA |
Venture Round | 04/05/22 | $2.55B | NA | NA |
Series C | 05/04/21 | $900.00M | $100.00M | $ 9.96 |
Series B | 03/16/20 | $725.16M | $28.00M | $ 10.03 |
Venture Round | 12/02/18 | $35.17M | $7.39M | $ 8.66 |
Venture Round | 07/11/18 | $24.79M | $11.65M | $ 6.84 |
Series A | 11/29/16 | $16.24M | $5.39M | $ 6.33 |
Equity Crowdfunding | 09/23/15 | $4.34M | $661.37K | $ 2.66 |
Seed Round | 04/26/15 | $6.07M | $1.64M | $ 3.22 |
Source: Multiple |
Valuation
The Oura Ring valuation is $5.2 billion based on the Series D funding round.
IPO Potential
The Oura Ring IPO date is currently unknown.
Brands with name recognition and enthusiastic customers are good candidates for public listings.
Customers make excellent long-term shareholders who want to share in the company’s success.
Oura Ring’s customer base skews wealthy because it is a premium brand. Therefore, offering IPO access to Oura customers is a potential way for the company to attract long-term shareholders.
The company boasts a deep bench of venture capital investors, many of whom have enjoyed an increase in their investment stake thanks to the doubling of its private stock price in December 2025.
With so many private investors, some will eventually be eager to cash out of their investments. An IPO remains the best way for private investors to reap rewards and for the company to raise additional funds.
However, many companies have chosen to remain private, providing liquidity through tender offers. Vuori is a similar consumer brand and sized company that completed a tender offer in 2024 to allow employees to liquidate shares. Oura could follow suit.
If Oura Ring eventually decides to pursue a public listing, watch for reporting about exploring a possible IPO with investment banks or a confidential S-1 filing with the SEC.
As a Finnish company, it may IPO in Europe. However, a North American IPO is more likely, with a significant portion of its employees and customers residing in the U.S. and a more favorable regulatory framework.
Bookmark this page for the latest developments.
How to Buy Oura Ring Stock
Since Oura is a private company, it is challenging to become an equity owner today.
I have seen limited pre-IPO availability to date. But the December 2025 funding round (and its increased valuation) could lead to more shares becoming available on the secondary marketplaces.
Another way to invest is through indirect ownership — owning the stock of companies with a venture stake in Oura.
Patient investors can wait for the IPO. Oura is an excellent candidate for a directed share program, where customers may potentially have an opportunity to invest.
1. Access Oura Ring stock via pre-IPO investing platforms
The author has not seen evidence of Oura Ring stock being available on pre-IPO platforms. However, retail investors can open an account with one or more leading pre-IPO investing platforms and monitor availability.
Some of the most active platforms for mid-to-late-stage startups include Hiive, Equitybee, EquityZen, Forge Global, and Linqto.
Pre-IPO investors must meet the SEC accreditation requirements. Minimum investments range from $1,000 to $50,000 or more for these different platforms.
Non-accredited retail investors can own pre-IPO companies by owning the Fundrise Innovation Fund, a venture capital fund.
However, investors cannot select individual pre-IPO companies, and Oura Ring stock is currently not present in the portfolio.
Please note: This is a testimonial in partnership with Fundrise. We earn a commission from partner links on AccessIPOs.com. All opinions are my own.
Check out our list of top pre-IPO investing platforms for current share availability across platforms.
2. Participate in the Oura IPO through a broker
The Oura Ring IPO is likely at least three to five years away, though it could come earlier if the IPO window opens for the broader startup environment.
Therefore, you’ll need to exercise patience and realistic expectations to become an owner via the IPO, which may never happen.
IPO investors may find opportunities to invest during the IPO when it arrives — acquiring shares at the IPO price the day before the stock begins trading on the open market.
Once a privilege of the affluent clientele of Wall Street, IPO access has become increasingly accessible to retail investors.
The following online brokers give customers free access to IPOs, even with low account balances:
TradeStation has a longer track record of accessing more than 400 IPOs and secondary offerings via its partnership with Click Markets.
But Robinhood has the advantage of Silicon Valley networks and a history of getting allocations for high-profile IPOs.
Read the S-1 filings to find mentions of these online brokers to find opportunities.
Check out this list of best brokers for IPO investing to learn more about IPO access for retail investors.
3. Invest indirectly through public companies
Two notable public companies have invested in Oura Ring. Investing in either one gives ordinary investors limited investment exposure to the future growth of the private company.
Dexcom (DXCM) is a continuous glucose monitor (CGM) company that is ubiquitous in the world of Type 1 diabetes.
The company’s device measures blood glucose levels, allowing people with diabetes to deliver the correct amount of insulin without a finger stick.
Oura and Dexcom announced a partnership in November 2024. Dexcom invested $75 million at a $5.2 billion valuation (about a 1.5% stake).
The deal allows for data flow between devices. But more exciting is the prospect that someday, people with diabetes will be able to monitor their blood glucose via the Oura Ring in a non-invasive way (CGMs insert a tube under the skin for readings).
Another notable investor is Block (SQ). When it was known as Square, Jack Dorsey led the company to invest in Oura. It is unclear what percentage Block now owns.
Retail investors can invest in either public company to gain investment exposure to Oura. However, exposure will be minuscule.
4. Invest via a potential directed share program
Customers-centric companies on a path to an IPO are sometimes open to offering IPO shares to customers. They use a directed share program (DSP) to accomplish this.
An S-1 filing allows a company to reserve a portion of its IPO shares for specific groups, such as employees, family, friends, customers, or business partners, at the IPO price.
The program aims to reward loyalty and engagement among stakeholders while allowing them to invest early. These shares are typically offered under specific terms and may have restrictions, such as lockup periods, to prevent immediate resale.
If you are an Oura Ring customer, monitor your associated email address in the month leading up to the IPO. Also, peruse the S-1 for information about the DSP (we’ll post the information on this page if such an opportunity emerges).
5. Buy the stock after the IPO
Most investors won’t gain access to pre-IPO shares or IPO allocations.
Investing post-IPO has benefits, such as the chance to review multiple quarters of financials which aren’t available pre-IPO. While IPO prices often rise with high-demand companies, post-IPO investors risk buying at inflated prices.
For instance, Rivian and Robinhood soared after their 2021 IPOs but dropped over 80% from their peaks within six months. Such declines can present excellent buying opportunities or ‘falling knife’ pitfalls.
Avoid overpaying immediately after an IPO, as stocks often drop after lockup expirations or disappointing earnings. Focus on disruptive companies with strong long-term potential — patience and selectivity are key.
Frequently Asked Questions (FAQs)
Is Oura Ring publicly traded?
No. Oura Ring is not publicly traded.
What is the Oura Ring stock price?
A public Oura Ring stock price does not exist because the company is private. We can look to pre-IPO marketplaces for a private stock price estimate.
The April 2022 funding round was completed at $14.26 per share, according to Caplight, a data provider.
At a $5.2 billion valuation, I estimate the December 2025 funding round to have taken place at around $31.50 per share.
What is the Oura Ring stock symbol?
There is no Oura Ring stock symbol yet because it is a private company.
“OURA” is available in the U.S. and will likely be the Oura Ring ticker symbol if there is an IPO.
Will Apple buy Oura Ring?
There are no indications that Oura Ring is for sale.
Apple, a leader in the wearables marketplace, would be a convenient suitor. Apple is said not to be developing a smart ring. But Apple has shied away from large acquisitions of wearable product producers, aside from the Beats acquisition.
Where is the Oura Ring S-1 Filing?
Oura Ring has yet to release an S-1 filing to the public. There is no evidence of a confidential S-1 filing yet.
Though CEO Tom Hale told Fierce Healthcare in November 2024 that Oura is profitable. Yet, the company chose to raise more private funds.
Profitability could be a sign that the Series D round is its last private round, or it may follow the trend of many tech companies and stay private.
News of a confidential or public S-1 filing would kick off the IPO process, suggesting the IPO could occur during the following two to six months. But first, we may hear of the firing of a CFO or speaking to investment banks, giving us timing clues.
When the company releases the S-1 filing to investors, we’ll link to and embed the document on this web page.
In the meantime, you can check out the most recent S-1 filings in our S-1 filings feed.
Oura Ring News Archive
04/05/2022: ŌURA Now Valued at $2.55 Billion
05/04/2021: ŌURA in The Age of Ownership
12/03/2018: ŌURA surpasses $20 million in funding
Conclusion
The Oura Ring is an emerging leader in the long-term and accelerating trend of innovative and personalized health-tracking solutions, offering a unique placement (on the finger).
As wearable technologies advance, Oura may expand into much-needed areas like non-invasive glucose monitoring, fertility, and mental health, potentially redefining the scope of biometric wearables.
With substantial backing from dozens of leading venture capitalist firms and sports celebrity investors, the company has demonstrated strong market appeal to customer interest.
However, its path to a public offering remains uncertain, with possibilities ranging from another private round, a tender offer, or an eventual IPO.
An Oura IPO could capitalize on its affluent customer base using a directed share program (via the SEC S-1 filing) to build long-term shareholder loyalty and strengthen the customer commitment to health.
Meanwhile, partnerships with companies like Dexcom hint at Oura’s ambition for broader capabilities and deeper integration into healthcare and wellness ecosystems.
Prospective investors can explore indirect ownership via Dexcom or Square and wait patiently for pre-IPO shares to become available on popular marketplaces.
If you want to become an Oura Ring stock investor, monitor the pre-IPO platforms mentioned in this article to prepare for investment opportunities.

Craig Stephens is a former IT professional who left his 19-year consulting career at the IRS to be a full-time finance writer. A DIY investor since 1995, he started Access IPOs in 2016 to provide a resource for ordinary investors pursuing access to IPOs. Craig studied Finance at Michigan State University and lives in Northern Virginia with his wife and three children. Learn more about Craig.
* This is a testimonial in partnership with Fundrise, Hiive, and other affiliate partners. We earn a commission from partner links on AccessIPOs.com. All opinions are my own. If you sign up with one of our partners through certain on this website, Access IPOs will be compensated at no additional cost to the reader. See the full disclosure here. Risk Statement: Investing in IPOs and pre-IPO startups involves significant risk. Do not invest in companies based solely on what is included in this article. Only invest in IPOs and pre-IPO companies with money you can afford to lose. Access IPOs is for informational purposes only. Mentions of specific investments should not be construed as financial advice. Conduct personalized research and consider consulting with an investment advisor before investing.